Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 95

1.

Comparison of simultaneous arterial spin labeling MRI and 15O-H2O PET measurements of regional cerebral blood flow in rest and altered perfusion states.

Puig O, Henriksen OM, Vestergaard MB, Hansen AE, Andersen FL, Ladefoged CN, Rostrup E, Larsson HB, Lindberg U, Law I.

J Cereb Blood Flow Metab. 2019 Sep 9:271678X19874643. doi: 10.1177/0271678X19874643. [Epub ahead of print]

PMID:
31500521
2.

Nerve-sparing versus non-nerve-sparing radical hysterectomy: surgical and long-term oncological outcomes.

Gil-Moreno A, Carbonell-Socias M, Salicrú S, Bradbury M, García Á, Vergés R, Puig OP, Sánchez-Iglesias JL, Cabrera-Díaz S, de la Torre J, Gómez-Hidalgo NR, Pérez-Benavente A, Díaz-Feijoo B.

Oncotarget. 2019 Jul 16;10(44):4598-4608. doi: 10.18632/oncotarget.27078. eCollection 2019 Jul 16.

3.

Case-control Indian buffet process identifies biomarkers of response to Codrituzumab.

Pradier MF, Reis B, Jukofsky L, Milletti F, Ohtomo T, Perez-Cruz F, Puig O.

BMC Cancer. 2019 Mar 28;19(1):278. doi: 10.1186/s12885-019-5472-0.

4.

Characterization of children and adolescents with psychosis risk syndrome: The Children and Adolescents Psychosis Risk Syndrome (CAPRIS) study.

Dolz M, Tor J, De la Serna E, Pardo M, Muñoz-Samons D, Rodríguez-Pascual M, Puig O, Sugranyes G, Usall J, Sánchez-Gistau V, Baeza I.

Early Interv Psychiatry. 2019 Oct;13(5):1062-1072. doi: 10.1111/eip.12728. Epub 2018 Nov 26.

PMID:
30478873
5.

Phase contrast mapping MRI measurements of global cerebral blood flow across different perfusion states - A direct comparison with 15O-H2O positron emission tomography using a hybrid PET/MR system.

Puig O, Vestergaard MB, Lindberg U, Hansen AE, Ulrich A, Andersen FL, Johannesen HH, Rostrup E, Law I, Larsson HB, Henriksen OM.

J Cereb Blood Flow Metab. 2018 Sep 11:271678X18798762. doi: 10.1177/0271678X18798762. [Epub ahead of print]

PMID:
30200799
6.

Comprehensive genetic testing for female and male infertility using next-generation sequencing.

Patel B, Parets S, Akana M, Kellogg G, Jansen M, Chang C, Cai Y, Fox R, Niknazar M, Shraga R, Hunter C, Pollock A, Wisotzkey R, Jaremko M, Bisignano A, Puig O.

J Assist Reprod Genet. 2018 Aug;35(8):1489-1496. doi: 10.1007/s10815-018-1204-7. Epub 2018 May 19.

7.

Combining expression of GPC3 in tumors and CD16 on NK cells from peripheral blood to identify patients responding to codrituzumab.

Chen G, Chen YC, Reis B, Belousov A, Jukofsky L, Rossin C, Muehlig A, Xu C, Essioux L, Ohtomo T, Di Laurenzio L, Puig O, Lee R.

Oncotarget. 2018 Jan 2;9(12):10436-10444. doi: 10.18632/oncotarget.23830. eCollection 2018 Feb 13.

8.

Evaluating Sex and Age Differences in ADI-R and ADOS Scores in a Large European Multi-site Sample of Individuals with Autism Spectrum Disorder.

Tillmann J, Ashwood K, Absoud M, Bölte S, Bonnet-Brilhault F, Buitelaar JK, Calderoni S, Calvo R, Canal-Bedia R, Canitano R, De Bildt A, Gomot M, Hoekstra PJ, Kaale A, McConachie H, Murphy DG, Narzisi A, Oosterling I, Pejovic-Milovancevic M, Persico AM, Puig O, Roeyers H, Rommelse N, Sacco R, Scandurra V, Stanfield AC, Zander E, Charman T.

J Autism Dev Disord. 2018 Jul;48(7):2490-2505. doi: 10.1007/s10803-018-3510-4.

9.

Evaluating genetic ancestry and self-reported ethnicity in the context of carrier screening.

Shraga R, Yarnall S, Elango S, Manoharan A, Rodriguez SA, Bristow SL, Kumar N, Niknazar M, Hoffman D, Ghadir S, Vassena R, Chen SH, Hershlag A, Grifo J, Puig O.

BMC Genet. 2017 Nov 28;18(1):99. doi: 10.1186/s12863-017-0570-y.

10.

Laparoscopic Isthmocele Repair with Hysteroscopic Assistance.

Suarez Salvador E, Haladjian MC, Bradbury M, Cubo-Abert M, Manalich Barrachina L, Vila Escude E, Puig OP, Gil-Moreno A.

J Minim Invasive Gynecol. 2018 May - Jun;25(4):576-577. doi: 10.1016/j.jmig.2017.10.005. Epub 2017 Oct 12.

PMID:
29032251
11.

Persistent Negative Symptoms in First-Episode Psychosis: Early Cognitive and Social Functioning Correlates and Differences Between Early and Adult Onset.

Puig O, Baeza I, de la Serna E, Cabrera B, Mezquida G, Bioque M, Lobo A, González-Pinto A, Parellada M, Corripio I, Vieta E, Bobes J, Usall J, Contreras F, Cuesta MJ, Bernardo M, Castro-Fornieles J; PEPs Group.

J Clin Psychiatry. 2017 Nov/Dec;78(9):1414-1422. doi: 10.4088/JCP.16m11122.

PMID:
28922588
12.

Clinical high risk for psychosis in children and adolescents: a systematic review.

Tor J, Dolz M, Sintes A, Muñoz D, Pardo M, de la Serna E, Puig O, Sugranyes G, Baeza I.

Eur Child Adolesc Psychiatry. 2018 Jun;27(6):683-700. doi: 10.1007/s00787-017-1046-3. Epub 2017 Sep 15. Review.

PMID:
28914382
13.

Broad Cognitive Profile in Children and Adolescents with HF-ASD and in Their Siblings: Widespread Underperformance and its Clinical and Adaptive Correlates.

Rosa M, Puig O, Lázaro L, Vallés V, Lera S, Sánchez-Gistau V, Calvo R.

J Autism Dev Disord. 2017 Jul;47(7):2153-2162. doi: 10.1007/s10803-017-3137-x.

PMID:
28455721
14.

Intrinsic functional connectivity of fronto-temporal networks in adolescents with early psychosis.

Solé-Padullés C, Castro-Fornieles J, de la Serna E, Sánchez-Gistau V, Romero S, Puig O, Calvo A, Bargalló N, Baeza I, Sugranyes G.

Eur Child Adolesc Psychiatry. 2017 Jun;26(6):669-679. doi: 10.1007/s00787-016-0931-5. Epub 2016 Dec 28.

PMID:
28032201
16.

Age as a moderator of change following compensatory cognitive training in individuals with severe mental illnesses.

Thomas KR, Puig O, Twamley EW.

Psychiatr Rehabil J. 2017 Mar;40(1):70-78. doi: 10.1037/prj0000206. Epub 2016 Aug 22.

17.

Prospective Randomized Trial Comparing Transperitoneal Versus Extraperitoneal Laparoscopic Aortic Lymphadenectomy for Surgical Staging of Endometrial and Ovarian Cancer: The STELLA Trial.

Díaz-Feijoo B, Correa-Paris A, Pérez-Benavente A, Franco-Camps S, Sánchez-Iglesias JL, Cabrera S, de la Torre J, Centeno C, Puig OP, Gil-Ibañez B, Colas E, Magrina J, Gil-Moreno A.

Ann Surg Oncol. 2016 Sep;23(9):2966-74. doi: 10.1245/s10434-016-5229-9. Epub 2016 Apr 20.

PMID:
27098143
18.

Randomized phase II placebo controlled study of codrituzumab in previously treated patients with advanced hepatocellular carcinoma.

Abou-Alfa GK, Puig O, Daniele B, Kudo M, Merle P, Park JW, Ross P, Peron JM, Ebert O, Chan S, Poon TP, Colombo M, Okusaka T, Ryoo BY, Minguez B, Tanaka T, Ohtomo T, Ukrainskyj S, Boisserie F, Rutman O, Chen YC, Xu C, Shochat E, Jukofsky L, Reis B, Chen G, Di Laurenzio L, Lee R, Yen CJ.

J Hepatol. 2016 Aug;65(2):289-95. doi: 10.1016/j.jhep.2016.04.004. Epub 2016 Apr 13.

PMID:
27085251
20.

Antitumor activity of alectinib, a selective ALK inhibitor, in an ALK-positive NSCLC cell line harboring G1269A mutation: Efficacy of alectinib against ALK G1269A mutated cells.

Yoshimura Y, Kurasawa M, Yorozu K, Puig O, Bordogna W, Harada N.

Cancer Chemother Pharmacol. 2016 Mar;77(3):623-8. doi: 10.1007/s00280-016-2977-y. Epub 2016 Feb 5.

PMID:
26849637
21.

Alectinib in ALK-positive, crizotinib-resistant, non-small-cell lung cancer: a single-group, multicentre, phase 2 trial.

Shaw AT, Gandhi L, Gadgeel S, Riely GJ, Cetnar J, West H, Camidge DR, Socinski MA, Chiappori A, Mekhail T, Chao BH, Borghaei H, Gold KA, Zeaiter A, Bordogna W, Balas B, Puig O, Henschel V, Ou SI; study investigators.

Lancet Oncol. 2016 Feb;17(2):234-242. doi: 10.1016/S1470-2045(15)00488-X. Epub 2015 Dec 19. Erratum in: Lancet Oncol. 2017 Mar;18(3):e134.

22.

Assessing Advanced Theory of Mind in Children and Adolescents with High-Functioning Autism: The Spanish Version of the Stories of Everyday Life.

Lera-Miguel S, Rosa M, Puig O, Kaland N, Lázaro L, Castro-Formieles J, Calvo R.

J Autism Dev Disord. 2016 Jan;46(1):294-304. doi: 10.1007/s10803-015-2585-4.

PMID:
26347232
23.

Refractory status epilepticus due to SMART syndrome.

Jaraba S, Puig O, Miró J, Velasco R, Castañer S, Rodríguez L, Izquierdo C, Simó M, Veciana M, Falip M.

Epilepsy Behav. 2015 Aug;49:189-92. doi: 10.1016/j.yebeh.2015.05.033. Epub 2015 Jun 11.

PMID:
26071996
24.

Vagus nerve stimulation therapy is effective and safe for startle-induced seizures.

Miró J, Jaraba S, Mora J, Puig O, Castañer S, Rodriguez-Bel L, Santurino M, Plans G, Falip M.

J Neurol Sci. 2015 Jul 15;354(1-2):124-6. doi: 10.1016/j.jns.2015.04.048. Epub 2015 May 7. No abstract available.

PMID:
25979636
25.

Cognitive remediation therapy in adolescents with early-onset schizophrenia: a randomized controlled trial.

Puig O, Penadés R, Baeza I, De la Serna E, Sánchez-Gistau V, Bernardo M, Castro-Fornieles J.

J Am Acad Child Adolesc Psychiatry. 2014 Aug;53(8):859-68. doi: 10.1016/j.jaac.2014.05.012. Epub 2014 Jun 21.

PMID:
25062593
26.

Laparoscopic repair of non-complicated lumbar hernia secondary to a latissimus dorsi flap.

Obregón L, Ruiz-Castilla M, Binimelis MM, Guinot A, García V, Puig O, Barret JP.

J Plast Reconstr Aesthet Surg. 2014 Mar;67(3):407-10. doi: 10.1016/j.bjps.2013.07.022. Epub 2013 Jul 31.

PMID:
23910913
27.

Assessment of real-world daily-living skills in early-onset schizophrenia trough the Life Skills Profile scale.

Puig O, Penadés R, Baeza I, De la Serna E, Sánchez-Gistau V, Lázaro L, Bernardo M, Castro-Fornieles J.

Schizophr Res. 2013 Apr;145(1-3):95-100. doi: 10.1016/j.schres.2012.12.026. Epub 2013 Feb 4.

PMID:
23384737
28.

Cognitive reserve as a predictor of two year neuropsychological performance in early onset first-episode schizophrenia.

de la Serna E, Andrés-Perpiñá S, Puig O, Baeza I, Bombin I, Bartrés-Faz D, Arango C, Gonzalez-Pinto A, Parellada M, Mayoral M, Graell M, Otero S, Guardia J, Castro-Fornieles J.

Schizophr Res. 2013 Jan;143(1):125-31. doi: 10.1016/j.schres.2012.10.026. Epub 2012 Nov 20.

PMID:
23182439
29.

Systems biology approach for new target and biomarker identification.

Wang IM, Stone DJ, Nickle D, Loboda A, Puig O, Roberts C.

Curr Top Microbiol Immunol. 2013;363:169-99. doi: 10.1007/82_2012_252. Review.

PMID:
22903568
30.

Regression of atherosclerosis is characterized by broad changes in the plaque macrophage transcriptome.

Feig JE, Vengrenyuk Y, Reiser V, Wu C, Statnikov A, Aliferis CF, Garabedian MJ, Fisher EA, Puig O.

PLoS One. 2012;7(6):e39790. doi: 10.1371/journal.pone.0039790. Epub 2012 Jun 27.

31.

The gamma secretase inhibitor MRK-003 attenuates pancreatic cancer growth in preclinical models.

Mizuma M, Rasheed ZA, Yabuuchi S, Omura N, Campbell NR, de Wilde RF, De Oliveira E, Zhang Q, Puig O, Matsui W, Hidalgo M, Maitra A, Rajeshkumar NV.

Mol Cancer Ther. 2012 Sep;11(9):1999-2009. doi: 10.1158/1535-7163.MCT-12-0017. Epub 2012 Jul 2.

32.

Processing speed and executive functions predict real-world everyday living skills in adolescents with early-onset schizophrenia.

Puig O, Penadés R, Baeza I, Sánchez-Gistau V, De la Serna E, Fonrodona L, Andrés-Perpiñá S, Bernardo M, Castro-Fornieles J.

Eur Child Adolesc Psychiatry. 2012 Jun;21(6):315-26. doi: 10.1007/s00787-012-0262-0. Epub 2012 Feb 22.

PMID:
22354179
33.

Location of aortic node metastases in locally advanced cervical cancer.

Gil-Moreno A, Magrina JF, Pérez-Benavente A, Díaz-Feijoo B, Sánchez-Iglesias JL, García A, Cabrera-Díaz S, Puig O, Martínez-Gómez X, Xercavins J.

Gynecol Oncol. 2012 May;125(2):312-4. doi: 10.1016/j.ygyno.2012.02.008. Epub 2012 Feb 12.

PMID:
22333995
34.

Two-year follow-up of cognitive functions in schizophrenia spectrum disorders of adolescent patients treated with electroconvulsive therapy.

de la Serna E, Flamarique I, Castro-Fornieles J, Pons A, Puig O, Andrés-Perpiña S, Lázaro L, Garrido JM, Bernardo M, Baeza I.

J Child Adolesc Psychopharmacol. 2011 Dec;21(6):611-9. doi: 10.1089/cap.2011.0012. Epub 2011 Dec 2.

PMID:
22136098
35.

Metabolic syndrome in mice induced by expressing a transcriptional activator in adipose tissue.

Zhang L, Zhou Y, Zhu AY, Li XQ, Mundt SS, Gao L, Lisnock J, Hernandez M, Alonso-Galicia M, Springer MS, O'Neill EA, Daugherty BL, Puig O.

Transgenic Res. 2012 Jun;21(3):633-44. doi: 10.1007/s11248-011-9562-2. Epub 2011 Oct 26.

PMID:
22038448
36.

Plasma lipid profiling across species for the identification of optimal animal models of human dyslipidemia.

Yin W, Carballo-Jane E, McLaren DG, Mendoza VH, Gagen K, Geoghagen NS, McNamara LA, Gorski JN, Eiermann GJ, Petrov A, Wolff M, Tong X, Wilsie LC, Akiyama TE, Chen J, Thankappan A, Xue J, Ping X, Andrews G, Wickham LA, Gai CL, Trinh T, Kulick AA, Donnelly MJ, Voronin GO, Rosa R, Cumiskey AM, Bekkari K, Mitnaul LJ, Puig O, Chen F, Raubertas R, Wong PH, Hansen BC, Koblan KS, Roddy TP, Hubbard BK, Strack AM.

J Lipid Res. 2012 Jan;53(1):51-65. doi: 10.1194/jlr.M019927. Epub 2011 Oct 23.

37.

A gene expression signature that classifies human atherosclerotic plaque by relative inflammation status.

Puig O, Yuan J, Stepaniants S, Zieba R, Zycband E, Morris M, Coulter S, Yu X, Menke J, Woods J, Chen F, Ramey DR, He X, O'Neill EA, Hailman E, Johns DG, Hubbard BK, Yee Lum P, Wright SD, Desouza MM, Plump A, Reiser V.

Circ Cardiovasc Genet. 2011 Dec;4(6):595-604. doi: 10.1161/CIRCGENETICS.111.960773. Epub 2011 Oct 18.

PMID:
22010137
38.

Clinical and biological correlates of adolescent anorexia nervosa with impaired cognitive profile.

Andrés-Perpiña S, Lozano-Serra E, Puig O, Lera-Miguel S, Lázaro L, Castro-Fornieles J.

Eur Child Adolesc Psychiatry. 2011 Dec;20(11-12):541-9. doi: 10.1007/s00787-011-0216-y. Epub 2011 Oct 8. Erratum in: Eur Child Adolesc Psychiatry. 2014 Sep;23(9):851.

PMID:
21984403
39.

Cdkn2a is an atherosclerosis modifier locus that regulates monocyte/macrophage proliferation.

Kuo CL, Murphy AJ, Sayers S, Li R, Yvan-Charvet L, Davis JZ, Krishnamurthy J, Liu Y, Puig O, Sharpless NE, Tall AR, Welch CL.

Arterioscler Thromb Vasc Biol. 2011 Nov;31(11):2483-92. doi: 10.1161/ATVBAHA.111.234492.

40.

Reduced penetrance of autosomal dominant hypercholesterolemia in a high percentage of families: importance of genetic testing in the entire family.

Garcia-Garcia AB, Ivorra C, Martinez-Hervas S, Blesa S, Fuentes MJ, Puig O, Martín-de-Llano JJ, Carmena R, Real JT, Chaves FJ.

Atherosclerosis. 2011 Oct;218(2):423-30. doi: 10.1016/j.atherosclerosis.2011.07.106. Epub 2011 Jul 30.

PMID:
21868016
41.

Comparison between young siblings and offspring of subjects with schizophrenia: clinical and neuropsychological characteristics.

de la Serna E, Baeza I, Andrés S, Puig O, Sánchez-Guistau V, Romero S, Bernardo M, Moreno D, Noguera A, Castro-Fornieles J.

Schizophr Res. 2011 Sep;131(1-3):35-42. doi: 10.1016/j.schres.2011.06.015. Epub 2011 Jul 7.

PMID:
21741217
42.

Translational biomarkers: from preclinical to clinical a report of 2009 AAPS/ACCP Biomarker Workshop.

Bai JP, Bell R, Buckman S, Burckart GJ, Eichler HG, Fang KC, Goodsaid FM, Jusko WJ, Lesko LL, Meibohm B, Patterson SD, Puig O, Smerage JB, Snider BJ, Wagner JA, Wang J, Walton MK, Weiner R.

AAPS J. 2011 Jun;13(2):274-83. doi: 10.1208/s12248-011-9265-x. Epub 2011 Mar 30. Erratum in: AAPS J. 2011 Sep;13(3):493.

43.

siRNA-induced liver ApoB knockdown lowers serum LDL-cholesterol in a mouse model with human-like serum lipids.

Tadin-Strapps M, Peterson LB, Cumiskey AM, Rosa RL, Mendoza VH, Castro-Perez J, Puig O, Zhang L, Strapps WR, Yendluri S, Andrews L, Pickering V, Rice J, Luo L, Chen Z, Tep S, Ason B, Somers EP, Sachs AB, Bartz SR, Tian J, Chin J, Hubbard BK, Wong KK, Mitnaul LJ.

J Lipid Res. 2011 Jun;52(6):1084-97. doi: 10.1194/jlr.M012872. Epub 2011 Mar 11.

44.

Altered lipoprotein metabolism in P2Y(13) knockout mice.

Blom D, Yamin TT, Champy MF, Selloum M, Bedu E, Carballo-Jane E, Gerckens L, Luell S, Meurer R, Chin J, Mudgett J, Puig O.

Biochim Biophys Acta. 2010 Dec;1801(12):1349-60. doi: 10.1016/j.bbalip.2010.08.013. Epub 2010 Sep 15.

PMID:
20817122
45.

Understanding Forkhead box class O function: lessons from Drosophila melanogaster.

Puig O, Mattila J.

Antioxid Redox Signal. 2011 Feb 15;14(4):635-47. doi: 10.1089/ars.2010.3407. Epub 2010 Oct 20. Review.

PMID:
20618068
46.

Transcriptome profiling and network analysis of genetically hypertensive mice identifies potential pharmacological targets of hypertension.

Puig O, Wang IM, Cheng P, Zhou P, Roy S, Cully D, Peters M, Benita Y, Thompson J, Cai TQ.

Physiol Genomics. 2010 Sep;42A(1):24-32. doi: 10.1152/physiolgenomics.00010.2010. Epub 2010 Jun 29.

PMID:
20587620
47.

Executive function needs to be targeted to improve social functioning with Cognitive Remediation Therapy (CRT) in schizophrenia.

Penadés R, Catalán R, Puig O, Masana G, Pujol N, Navarro V, Guarch J, Gastó C.

Psychiatry Res. 2010 May 15;177(1-2):41-5. doi: 10.1016/j.psychres.2009.01.032. Epub 2010 Apr 9.

PMID:
20381164
48.

Molecular characterization and susceptibility testing of Helicobacter pylori strains isolated in western Argentina.

Vega AE, Cortiñas TI, Puig ON, Silva HJ.

Int J Infect Dis. 2010 Sep;14 Suppl 3:e85-92. doi: 10.1016/j.ijid.2009.11.022. Epub 2010 Mar 20.

49.

Is memory impairment a rate limiter in cognitive behavioural therapy for chronic schizophrenia?

Penadés R, Catalán R, Pujol N, Puig O, Guarch J, Masana G, Navarro V, Gastó C.

Psychother Psychosom. 2010;79(2):129-30. doi: 10.1159/000276378. Epub 2010 Jan 20. No abstract available.

PMID:
20090401
50.

Insights to transcriptional networks by using high throughput RNAi strategies.

Mattila J, Puig O.

Brief Funct Genomics. 2010 Jan;9(1):43-52. doi: 10.1093/bfgp/elp046. Epub 2009 Dec 1. Review.

Supplemental Content

Support Center